Nonalcoholic steatohepatitis: risk factors for liver fibrosis

被引:66
|
作者
Shimada, M [1 ]
Hashimoto, E [1 ]
Kaneda, H [1 ]
Noguchi, S [1 ]
Hayashi, N [1 ]
机构
[1] Tokyo Womens Med Coll, Inst Gastroenterol, Tokyo, Japan
关键词
nonalcoholic steatohepatitis; liver fibrosis; liver cirrhosis; steatohepatitis; Mallory body;
D O I
10.1016/S1386-6346(02)00246-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The purpose of this study was to clarify the clinicopathological features of nonalcoholic steatohepatitis (NASH) and identify risk factors for severe hepatic fibrosis. Materials and Methods: Eighty-one patients with biopsy-proven NASH were studied. In all patients, the diagnosis of NASH was established on the basis of following criteria: (1) the presence of steatosis, lobular inflammation, and ballooning degeneration on liver biopsy, (2) intake of less than 20 g of ethanol per week, and (3) appropriate exclusion of other liver diseases. Results: The median age was 54 years (range: 21-82 years) and 41 patients were women (51%). Obesity was present in 58 patients (72%), while 25 patients (31%) had diabetes mellitus and 33 patients (41%) had hyperlipidemia. Histologically, 58 patients (72%) had trivial to moderate fibrosis, 6 patients (7%) had bridging fibrosis, and 17 patients (21%) had established cirrhosis. Multiple logistic regression analysis assessed clinical, laboratory and histological factors showed that the risk factors for fibrosis were a low platelet count (P = 0.0016), a high AST/ALT ratio (P = 0.0229), and the presence of Mallory bodies (P = 0.0209). To exclude factors that were a consequence of liver cirrhosis, variables included in the multiple logistic analysis were age, gender, diabetes, obesity, and hyperlipidemia. This showed that older age (P=0.0037) and the absence of hyperlipidemia (P = 0.0150) were risk factors for fibrosis. Conclusions: We found that a low platelet count, a high AST/ALT ratio, and the presence of Mallory bodies were significant predictors of severe liver fibrosis. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:429 / 438
页数:10
相关论文
共 50 条
  • [21] Cellular stress in the pathogenesis of nonalcoholic steatohepatitis and liver fibrosis
    Sachin Sharma
    Dounia Le Guillou
    Jennifer Y. Chen
    Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 662 - 678
  • [22] GALLSTONE DISEASE IS NOT ASSOCIATED WITH LIVER FIBROSIS AND NONALCOHOLIC STEATOHEPATITIS IN NONALCOHOLIC FATTY LIVER DISEASE
    Yilmaz, Y.
    Ayyildiz, T.
    Akin, H.
    Colak, Y.
    Ozturk, O.
    Senates, E.
    Tuncer, I.
    Dolar, E.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S553 - S554
  • [23] Liver fibrosis in the context of nonalcoholic steatohepatitis: the role of adipokines
    Di Maira, Giovanni
    Pastore, Mirella
    Marra, Fabio
    MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2018, 64 (01) : 39 - 50
  • [24] Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis
    Uslusoy, Hiseyin Saadettin
    Nak, Selim Giray
    Gulten, Macit
    WORLD JOURNAL OF HEPATOLOGY, 2011, 3 (08) : 219 - 227
  • [25] Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
    Angulo, P
    Keach, JC
    Batts, KP
    Lindor, KD
    HEPATOLOGY, 1999, 30 (06) : 1356 - 1362
  • [26] Correlation of clinical and laboratory factors with fibrosis in nonalcoholic steatohepatitis
    Lee, Tae Hoon
    Tekleyes, Fikadu
    Pacioles, Toni
    Shora, Waseem
    Ahmed, Monjur
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S161 - S162
  • [27] Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis
    Younossi, Zobair M.
    Loomba, Rohit
    Anstee, Quentin M.
    Rinella, Mary E.
    Bugianesi, Elisabetta
    Marchesini, Giulio
    Neuschwander-Tetri, Brent A.
    Serfaty, Lawrence
    Negro, Francesco
    Caldwell, Stephen H.
    Ratziu, Vlad
    Corey, Kathleen E.
    Friedman, Scott L.
    Abdelmalek, Manal F.
    Harrison, Stephen A.
    Sanyal, Arun J.
    Lavine, Joel E.
    Mathurin, Philippe
    Charlton, Michael R.
    Goodman, Zachary D.
    Chalasani, Naga P.
    Kowdley, Kris V.
    George, Jacob
    Lindor, Keith
    HEPATOLOGY, 2018, 68 (01) : 349 - 360
  • [28] Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
    Zhu, Changyu
    Kim, KyeongJin
    Wang, Xiaobo
    Bartolome, Alberto
    Salomao, Marcela
    Dongiovanni, Paola
    Meroni, Marica
    Graham, Mark J.
    Yates, Katherine P.
    Diehl, Anna Mae
    Schwabe, Robert F.
    Tabas, Ira
    Valenti, Luca
    Lavine, Joel E.
    Pajvani, Utpal B.
    SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (468)
  • [29] Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
    Angulo, P
    Keach, JC
    Batts, KP
    Lindor, KD
    HEPATOLOGY, 1999, 30 (04) : 406A - 406A
  • [30] Clinical and Histologic Characterization of Steatotic HCV Liver Biopsy: Central Portalization Correlates with Fibrosis but Not with Risk Factors for Nonalcoholic Steatohepatitis (NASH)
    Lee, H.
    Dresser, K.
    Kurian, E. M.
    MODERN PATHOLOGY, 2014, 27 : 424A - 424A